Medical/Pharmaceuticals

Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success

SINGAPORE, March 12, 2024 /PRNewswire/ -- From March 7 to 8, 2024, the International Society of Organoid Research (ISoOR) convened its 2024 annual meeting, after the successful conference inSingapore last year. This year, the conference was held in the vibrant city ofShanghai, China, reflecting t...

2024-03-12 11:57 1594

TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation

LUND, Sweden, March 12, 2024 /PRNewswire/ -- TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia. This strategic move marks a significant m...

2024-03-12 10:52 1682

Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, March 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmu...

2024-03-12 08:00 1743

SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada

Milestone Coincides with SK Biopharmaceuticals' Global Plan Expanding Cenobamate Access to More Than 100 Markets Worldwide SEOUL, South Korea and ROME, March 12, 2024 /PRNewswire/ -- SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous system (CN...

2024-03-12 08:00 1440

Cell Impact has received an order worth SEK 18 million in the field of electrolysis

KARLSKOGA, Sweden, March 12, 2024 /PRNewswire/ -- Cell Impact has signed an agreement concerning flow plates, tools, and fixtures to a value of just over SEK 18 million. The contract marks a significant step for Cell Impact into the electrolyzer market.

2024-03-12 06:48 1736

Appointment of Dr Darren Patti to Group Chief Operating Officer

MELBOURNE, Australia, March 12, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr.Darren Patti as Group Chief Operating Officer (COO), effective 11 March 2024. Dr. Patti joined Telix in March 2021 to lead the Company'...

2024-03-12 05:44 1446

ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results

SEOUL, South Korea, March 11, 2024 /PRNewswire/ -- ImmunAbs, a leading clinical-stage biotechnology company focused on developing novel antibody therapeutics, today announced the successful completion of the Phase 1 clinical trial for IM-101. IM-101 is a humanized monoclonal antibody targeting...

2024-03-11 17:00 1877

Upcoming 89th CMEF in Shanghai to Showcase Innovative Technological Advancements Spanning the Entire Value Chain of the Medical Equipment Industry

SHANGHAI, March 11, 2024 /PRNewswire/ -- The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place fromApril 11th to 14th in Shanghai. The industry-leading tradeshow will draw nearly 5,000 global exhibitors from over 20 countries, with an expected audience of over 200,...

2024-03-11 15:20 1673

AI Empowers Surgery: CAIR unveils its latest large multimodality model for surgery

HONG KONG, March 11, 2024 /PRNewswire/ -- As artificial intelligence technology continues to advance, it has accelerated intelligent innovation across various industries. Breakthroughs in AI technologies like GPT have gained widespread attention, especially in the healthcare sector, where they of...

2024-03-11 15:06 1405

Apollo Hospitals Unveils South Asia's First ZAP-X, Transforming Brain Tumor Care

NEW DELHI, March 11, 2024 /PRNewswire/ -- Apollo Hospitals becomes the first hospital to introduce ZAP-X Gyroscopic Radiosurgery Platform, a significant milestone as the first inSouth Asia to introduce this ground-breaking technology. ZAP-X introduces a new era in brain tumor treatment, offering ...

2024-03-11 15:00 1534

Fullerton Health Deepens Commitment to Community Health with Health Hub Clinics in the Heartlands

SINGAPORE, March 11, 2024 /PRNewswire/ -- In line with Fullerton Health's purpose of affordable and accessible care for all, residents living in Hougang will now be able to enjoy the full range of primary care , preventive health and diagnostic services closer to home at Fullerton Health Hub @ Ho...

2024-03-11 14:00 1462

RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024

YANTAI, China, March 11, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently gave an oral presentation on an interim analysis of the evaluation of the Company's proprietary Disitamab ...

2024-03-11 10:36 1355

APPIS 2024: Healthcare Stakeholders Come Together to Prioritize Action for Better Patient Outcomes in Asia Pacific, Middle East, and Africa

* Since 2021, the APPIS platform has brought together over 2,000 people from more than 65 countries to address barriers to healthcare access. * Over 40 healthcare expert speakers will cover critical topics from health literacy, health policy shaping and future readiness at the APPIS Summit 202...

2024-03-11 10:00 1846

Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau

-- Macau is on course to become the first of Everest's Asian territories to get etrasimod approval -- Can provide access to patients in China's Greater Bay area and rest of Asia SHANGHAI, March 11, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceu...

2024-03-11 09:00 2293

Launch of CMDF Showcase Event to Share Achievements, Promote Chinese Medicine Culture to Public and Remark a New Mileage of Chinese Medicine Development

HONG KONG, March 9, 2024 /PRNewswire/ -- In 2019, the HKSAR Government officially launched the Chinese Medicine Development Fund (CMDF) to promote the development and elevate the overall standards of the Chinese medicine (CM) sector inHong Kong. Starting from today, the CMDF will host a four-day ...

2024-03-09 18:17 2512

"AXA Women's Health Centre" officially unveils on International Women's Day

AXA and Chiron Medical join hands to introduce Hong Kong's first women-exclusive health centre Comprehensive care for women's health with an entire female medical team at the helm HONG KONG, March 8, 2024 /PRNewswire/ -- Commemorating International Women's Day on 8 March, AXA Hong Kong andMacau ...

2024-03-08 19:49 2232

Uniting for Women's Wellness on IWD - From China to Uzbekistan

- Interviewing Wang Leilei, the first blind model in China, and Viktoriya Tsay, head of Prenatal and Neonatal Medicine Department at Genscreen, BGI Genomics JV laboratory inUzbekistan. HONG KONG, March 8, 2024 /PRNewswire/ -- To mark International Women's Day (IWD), BGI Genomics interviewed Wang...

2024-03-08 08:07 2145

Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024

ROCKVILLIE, Md. and SUZHOU, China, March 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and...

2024-03-07 11:53 2467

Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

Reshaping the landscape for the second-line treatments of Small Cell Lung Cancer HONG KONG and MACAO, March 7, 2024 /PRNewswire/ -- A symposium called the New Treatment Paradigm for Small Cell Lung Cancer (SCLC) organized by the Hong Kong Cancer Therapy Society (HKCTS) with support from Luye Phar...

2024-03-07 10:11 1975

A Global Milestone in Innovative Pancreatic Cancer Therapy

Suppression of pancreatic cancer and increased survival rates in animals implanted with human pancreatic cancer cells when treated with biologic agent BGX, a proprietary targeted therapy developed in-house by BioGate. TAIPEI, March 7, 2024 /PRNewswire/ -- BioGate Precision Medicine Corp., a memb...

2024-03-07 10:00 1765
1 ... 567891011 ... 382